S&P 500   4,583.33 (-1.55%)
DOW   34,564.54 (-1.63%)
QQQ   392.09 (-1.90%)
AAPL   163.01 (+1.73%)
MSFT   330.65 (-1.78%)
FB   327.44 (-3.13%)
GOOGL   2,852.57 (-1.99%)
AMZN   3,499.99 (-1.73%)
TSLA   1,124.11 (-1.13%)
NVDA   321.29 (-3.74%)
BABA   126.39 (-3.97%)
NIO   38.44 (-4.99%)
CGC   10.33 (-6.60%)
AMD   156.88 (-3.11%)
GE   94.87 (-3.59%)
MU   84.70 (-1.67%)
T   22.56 (-5.57%)
F   19.11 (-2.85%)
DIS   143.60 (-2.85%)
ACB   6.13 (-4.81%)
AMC   33.25 (-9.74%)
PFE   53.57 (+2.23%)
BA   193.94 (-2.30%)
S&P 500   4,583.33 (-1.55%)
DOW   34,564.54 (-1.63%)
QQQ   392.09 (-1.90%)
AAPL   163.01 (+1.73%)
MSFT   330.65 (-1.78%)
FB   327.44 (-3.13%)
GOOGL   2,852.57 (-1.99%)
AMZN   3,499.99 (-1.73%)
TSLA   1,124.11 (-1.13%)
NVDA   321.29 (-3.74%)
BABA   126.39 (-3.97%)
NIO   38.44 (-4.99%)
CGC   10.33 (-6.60%)
AMD   156.88 (-3.11%)
GE   94.87 (-3.59%)
MU   84.70 (-1.67%)
T   22.56 (-5.57%)
F   19.11 (-2.85%)
DIS   143.60 (-2.85%)
ACB   6.13 (-4.81%)
AMC   33.25 (-9.74%)
PFE   53.57 (+2.23%)
BA   193.94 (-2.30%)
S&P 500   4,583.33 (-1.55%)
DOW   34,564.54 (-1.63%)
QQQ   392.09 (-1.90%)
AAPL   163.01 (+1.73%)
MSFT   330.65 (-1.78%)
FB   327.44 (-3.13%)
GOOGL   2,852.57 (-1.99%)
AMZN   3,499.99 (-1.73%)
TSLA   1,124.11 (-1.13%)
NVDA   321.29 (-3.74%)
BABA   126.39 (-3.97%)
NIO   38.44 (-4.99%)
CGC   10.33 (-6.60%)
AMD   156.88 (-3.11%)
GE   94.87 (-3.59%)
MU   84.70 (-1.67%)
T   22.56 (-5.57%)
F   19.11 (-2.85%)
DIS   143.60 (-2.85%)
ACB   6.13 (-4.81%)
AMC   33.25 (-9.74%)
PFE   53.57 (+2.23%)
BA   193.94 (-2.30%)
S&P 500   4,583.33 (-1.55%)
DOW   34,564.54 (-1.63%)
QQQ   392.09 (-1.90%)
AAPL   163.01 (+1.73%)
MSFT   330.65 (-1.78%)
FB   327.44 (-3.13%)
GOOGL   2,852.57 (-1.99%)
AMZN   3,499.99 (-1.73%)
TSLA   1,124.11 (-1.13%)
NVDA   321.29 (-3.74%)
BABA   126.39 (-3.97%)
NIO   38.44 (-4.99%)
CGC   10.33 (-6.60%)
AMD   156.88 (-3.11%)
GE   94.87 (-3.59%)
MU   84.70 (-1.67%)
T   22.56 (-5.57%)
F   19.11 (-2.85%)
DIS   143.60 (-2.85%)
ACB   6.13 (-4.81%)
AMC   33.25 (-9.74%)
PFE   53.57 (+2.23%)
BA   193.94 (-2.30%)
NASDAQ:AVXL

Anavex Life Sciences Earnings Date, Estimates, & History

$18.37
-2.07 (-10.13%)
(As of 11/30/2021 12:16 PM ET)
Add
Compare
Today's Range
$18.37
$20.56
50-Day Range
$16.87
$23.31
52-Week Range
$4.51
$31.50
Volume
28,162 shs
Average Volume
815,729 shs
Market Capitalization
$1.40 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.68

Earnings Summary

Upcoming
Earnings Date
Feb. 10
Estimated

Actual EPS
(Nov. 24)
-$0.15

Consensus EPS
(Nov. 24)
-$0.15

Last Year's Q4 EPS
(12/27/2020)
-$0.10

Skip Charts & View Estimated and Actual Earnings Data

Anavex Life Sciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Anavex Life Sciences Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Anavex Life Sciences (NASDAQ:AVXL) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20211($0.08)($0.08)($0.08)
Q2 20211($0.08)($0.08)($0.08)
Q3 20211($0.08)($0.08)($0.08)

AVXL Earnings Information

Anavex Life Sciences last posted its earnings results on November 24th, 2021. The biotechnology company reported ($0.15) earnings per share for the quarter, meeting the consensus estimate of ($0.15). Anavex Life Sciences has generated ($0.53) earnings per share over the last year (($0.53) diluted earnings per share). Earnings for Anavex Life Sciences are expected to grow in the coming year, from ($0.63) to $0.29 per share. Anavex Life Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 10th, 2022 based off prior year's report dates.

Anavex Life Sciences (NASDAQ:AVXL) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
2/10/2022
(Estimated)
        
11/24/20219/30/2021($0.15)($0.15)($0.15)    
8/11/20216/30/2021($0.13)($0.14)($0.01)($0.14)    
5/12/20213/31/2021($0.12)($0.12)($0.12)  
2/10/202112/31/2020($0.11)($0.12)($0.01)($0.12)  
12/27/20209/30/2020($0.13)($0.10)+$0.03($0.10)  
8/6/20206/30/2020($0.14)($0.11)+$0.03($0.11)  
5/7/20203/31/2020($0.14)($0.12)+$0.02($0.12)  
2/6/2020Q1($0.14)($0.12)+$0.02($0.12)  
12/16/2019Q4 2019($0.15)($0.07)+$0.08($0.07)  
8/7/2019Q3 2019($0.17)($0.1426)+$0.0274($0.14)
5/8/20193/31/2019($0.14)($0.13)+$0.01($0.09)  
2/7/201912/31/2018($0.13)($0.16)($0.03)($0.16)
12/12/2018Q4 2018($0.11)($0.13)($0.02)($0.13)  
8/9/2018Q3 2018($0.10)($0.0630)+$0.0370($0.06)
5/10/2018Q2 2018($0.10)($0.1070)($0.0070)($0.11)
2/7/2018Q1 2018($0.09)($0.09)($0.09)
12/11/2017Q4 2017($0.10)($0.12)($0.02)($0.12)  
8/7/2017Q3 2017($0.09)($0.09)($0.09)
5/10/2017Q2 2017($0.09)($0.09)($0.14)
2/7/2017Q1 2017($0.0820)($0.0820)($0.08)
12/12/2016Q4 2016($0.08)($0.18)($0.10)($0.18)
8/11/2016Q316($0.09)($0.06)+$0.03($0.06)
5/11/2016Q2($0.16)($0.06)+$0.10($0.08)
2/8/2016Q116($0.12)($0.12)($0.12)
12/29/2015Q4 2015($0.54)($0.54)($0.54)
8/17/2015Q3 2015($0.08)($0.08)$0.08
5/15/2015Q2 2015($0.12)($0.12)($0.12)
2/18/2015Q1 2015($0.08)($0.08)($0.08)
12/30/2014Q4 2014($0.96)($0.96)($0.96)
8/13/2014Q3 2014($0.12)($0.12)($0.12)
5/15/2014Q2 2014($0.12)($0.12)($0.12)
2/14/2013Q1 2013($0.04)($0.04)($0.04)
12/22/2011Q4 2011($0.20)($0.20)($0.20)
(Earnings results data provided by Zacks Investment Research)












Anavex Life Sciences (NASDAQ:AVXL) Earnings Frequently Asked Questions

When is Anavex Life Sciences's earnings date?

Anavex Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 10th, 2022 based off last year's report dates. Learn more on AVXL's earnings history

Did Anavex Life Sciences beat their earnings estimates last quarter?

In the previous quarter, Anavex Life Sciences (NASDAQ:AVXL) reported ($0.15) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.15). Learn more on AVXL's earnings details

How can I listen to Anavex Life Sciences's earnings conference call?

The conference call for Anavex Life Sciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Anavex Life Sciences's conference call transcript?

The conference call transcript for Anavex Life Sciences's latest earnings report can be read online. Read Transcript

How much profit does Anavex Life Sciences generate each year?

Anavex Life Sciences (NASDAQ:AVXL) has a recorded net income of -$37.91 million. AVXL has generated -$0.53 earnings per share over the last four quarters.

What is Anavex Life Sciences's EPS forecast for next year?

Anavex Life Sciences's earnings are expected to grow from ($0.63) per share to $0.29 per share in the next year.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.